Abbott gets restraining order against ex-VP in COVID-19 trade secrets dispute
05-11-2020
Ken Wolter / Shutterstock.com
Abbott Laboratories must face allegations brought by Grifols Diagnostic and a Novartis subsidiary that its HIV testing products infringe a patent covering a method to create HIV proteins using recombinant DNA.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Abbott Laboratories, Grifols Diagnostic, Novartis, HIV testing products, patent infringement, natural phenomenon, patent invalidity
